SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (237)6/7/1998 3:33:00 PM
From: B.REVERE  Read Replies (1) | Respond to of 1722
 
Anthony, I am not familiar with patent protection worldwide,
but should I assume that those countries who honor patents
would not allow companies in their country to buy the drug from these rip-off artists. What recourse does Pfiser have in order to protect
their investment from this country who violates international trade
laws?

Anyone on the thread?



To: Anthony Wong who wrote (237)6/7/1998 8:28:00 PM
From: chirodoc  Read Replies (1) | Respond to of 1722
 
<<<<<THE DRUG Controller of India has granted a licence to Cipla Ltd and
Orchid Pharmaceuticals and Chemicals to export sildenafil citrat

Rip off artists are everywhere and we really cannot stop that unless we have a stick to beat them over the head with. i see no reason for india to listen to bill clinton.

There will be a lot of deaths and Cipla will make a boatload of money. but, when india asks the U.S. for a favor, we might just bring this up.

curtis


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News